AI assistant
Sending…
IONIS PHARMACEUTICALS INC — Director's Dealing 2024
May 13, 2024
30591_dirs_2024-05-13_14396284-b58a-43ee-9d2b-fec8b9904572.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2024-05-09
Reporting Person: WENDER JOSEPH H (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-05-09 | Common Stock | M | 16000 | $35.53 | Acquired | 128079 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-05-09 | Non-Qualified Stock Option (right to buy) | $35.53 | M | 16000 | Disposed | 2024-06-30 | Common Stock (16000) | Direct |
Footnotes
F1: Acquired as a result of exercising a stock option that was scheduled to expire on 6/30/2024.
More from IONIS PHARMACEUTICALS INC
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Proxy Solicitation & Information Statement
2026
Apr 23
Regulatory Filings
2026
Apr 21
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 24